Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Opens Service Center in Singapore

NEW YORK (GenomeWeb News) - Qiagen announced last night that it has opened a new service solutions center in Singapore to serve the entire Asia-Pacific region.

The facility joins the firm’s six existing centers in the US, Europe, and Japan.

Qiagen said that the new center will help it serve customers in the research, applied testing, pharmaceutical, and molecular diagnostics markets in the entire Asia-Pacific region including Australia. The facility also will provide customer care and technical service requests in regional languages including Korean, Mandarin, Cantonese, Malay, and English.

"With this investment we can better respond to the needs of each and every customer, and we can also extend our services to 24 hours a day, 7 days a week in the near future,” Qiagen CEO Peer M. Schatz said in a statement.

Qiagen recently expanded its operations in Singapore through the creation of Dx Assay, a molecular diagnostics joint venture with Bio*One Capital. The venture will collaborate with all of Qiagen’s development facilities, including Digene’s operations, in developing new assays.

Qiagen currently employs more than 50 staffers in Singapore.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.